David McKenney is currently the Vice President and Head of in vivo Pharmacology at Septerna, a position they have held since 2025. They previously served as the Vice President of Nonclinical Pharmacology and Translational Biology at Aditum Bio and have extensive experience in various leadership roles, including Head of in vivo Pharmacology at Bolt Biotherapeutics and Principal Scientist at Arpida. McKenney's academic background includes a Ph.D. in Pharmacy from The University of Manchester and a Post Doctoral fellowship in Vaccine Development from Harvard Medical School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices